After the vaccine, Berlin care home residents hope for visitors and good health
BERLIN, Jan 22 (Reuters) - Like most residents at her care home in Berlin, 43-year-old Kristina Lang agreed to receive the coronavirus vaccine when her turn came, but not without trepidation.
Pfizer finishes enrolling kids in its COVID-19 vaccine study
(Reuters) - Pfizer Inc said on Friday it had finished enrolling children aged between 12 and 15 in a study testing its COVID-19 vaccine, as the U.S. drugmaker seeks to expand the shot's use among different age groups.
CORRECTED-New COVID-19 variant defeats plasma treatment, may reduce vaccine efficacy
JOHANNESBURG, Jan 20 (Reuters) - The new COVID-19 variant identified in South Africa can evade the antibodies that attack it in treatments using blood plasma from previously recovered patients, and may reduce the efficacy of the current line of vaccines, scientists said on Wednesday.
BioNTech to provide 50 million needles to extract more vaccine doses
FRANKFURT/BERLIN (Reuters) - BioNTech is to supply 50 million specialty needles at no profit to countries struggling to extract a sixth dose from vials of its COVID-19 vaccine, while Europe's immunisation campaign is hampered by a temporary supply shortfall.
UPDATE 1-BioNTech to provide 50 mln needles to extract more vaccine doses
FRANKFURT/BERLIN, Jan 22 (Reuters) - BioNTech is to supply 50 million specialty needles at no profit to countries struggling to extract a sixth dose from vials of its COVID-19 vaccine, while Europe's immunization campaign is hampered by a temporary supply shortfall.
After 10 months of quarantine, chronically ill young German jumps vaccine queue
NIEDERBREITBACH, Germany (Reuters) - Since the outbreak of the coronavirus pandemic, chronically ill 30-year-old Benni Over has lived in strict domestic quarantine in the German resort town of Niederbreitbach with his parents, who look after him around the clock.
Investors sue Bayer over stock's slump in wake of Roundup litigation
FRANKFURT (Reuters) - Two law firms are suing Bayer for damages on behalf of shareholders, claiming the German group's management should have warned of the risk of lawsuits over the Roundup weedkiller when Bayer acquired Roundup maker Monsanto.
SPECIAL REPORT-How U.S. CDC missed chances to spot COVID's silent spread
Jan 22 (Reuters) - In early February, 57 people arrived at a Nebraska military base, among the first Americans evacuated from Wuhan, China, the epicenter of the new coronavirus outbreak. U.S. health officials knew very little then about the mysterious new virus, and the quarantined group offered an early opportunity to size up the threat.
UPDATE 1-Japan tourism push linked to surge in COVID-19 infections -study
TOKYO, Jan 22 (Reuters) - A domestic tourism campaign promoted by Japan's Prime Minister Yoshihide Suga may have contributed to a sharp increase in coronavirus infection cases in the country, a prominent adviser to the government's pandemic response said.
After big hack of U.S. government, Biden enlists 'world class' cybersecurity team
WASHINGTON/SAN FRANCISCO (Reuters) - President Joe Biden is hiring a group of national security veterans with deep cyber expertise, drawing praise from former defense officials and investigators as the U.S. government works to recover from one of the biggest hacks of its agencies attributed to Russian spies.
- More Science Headlines»